StockIQ.techMediWound Ltd. (MDWD) Stock Analysis
Free AI-powered analysis and research for MediWound Ltd. stock
Sector: Healthcare
Analyze MediWound Ltd. (MDWD) Stock
MediWound Ltd. (MDWD) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into MDWD stock performance, technical indicators, and AI-powered trading recommendations.
Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for MediWound Ltd. stock.
Analyze MDWD Now →📰 Latest Update
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
Thu, April 2, 2026 at 7:26 PM UTC 3 min read
MediWound announced that Vericel has been awarded a contract by BARDA for NexoBrid®, valued at up to $197 million. This contract is significant as it highlights the potential for revenue growth and market expansion for NexoBrid, a treatment for severe burns. Investors may view this development positively, as it underscores the product's viability and the company's strategic partnerships in the healthcare sector.
History
📈 Technical Analysis
RSI, MACD, moving averages, support/resistance levels, and momentum indicators for MediWound Ltd. (MDWD) stock.
🤖 AI Insights
AI-powered analysis of MediWound Ltd. (MDWD) fundamentals, growth prospects, and market position.
⚠️ Risk Assessment
Comprehensive risk analysis including volatility, sector risks, and market conditions for MediWound Ltd. stock.
Why Analyze MediWound Ltd. (MDWD) with StockIQ?
- ✅ Free AI-powered analysis of MediWound Ltd. (MDWD) stock
- ✅ Real-time technical indicators for MediWound Ltd. stock
- ✅ Comprehensive risk assessment for MDWD
- ✅ No credit card required